UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000058043
Receipt number R000066345
Scientific Title Outcomes and surgically induced astigmatism in manual small incision cataract surgery: a randomized clinical trial comparing various scleral incision techniques.
Date of disclosure of the study information 2025/06/02
Last modified on 2025/06/02 07:49:57

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Scleral Incision Shapes and Visual Outcomes in MSICS"

Acronym

SISVOM

Scientific Title

Outcomes and surgically induced astigmatism in manual small incision cataract surgery: a randomized clinical trial comparing various scleral incision techniques.

Scientific Title:Acronym

OSIAMSICS

Region

Africa


Condition

Condition

Cataract surgery

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The objective of this study is to evaluate and compare the impact of different scleral incision types straight, frown, and chevron on visual outcomes and surgically induced astigmatism (SIA) in patients undergoing manual small incision cataract surgery (MSICS). By analyzing the postoperative visual acuity and changes in corneal curvature, the study aims to determine which incision geometry offers the most favorable outcomes in terms of minimizing astigmatism and optimizing visual recovery. This is particularly relevant for resource limited settings where access to postoperative refractive correction is often restricted.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

"1- Surgically Induced Astigmatism (SIA):

- Quantified by the difference in keratometric values pre- and postoperatively.

- Compared across the three incision types (straight, frown, chevron).

2- Postoperative Visual Acuity:

- Uncorrected Visual Acuity (UCVA) and Best-Corrected Visual Acuity (BCVA) at 30 days post-surgery.

- Used to assess functional visual recovery."

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

3

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Straight Incision Arm: Patients receive MSICS with a straight scleral incision.

Interventions/Control_2

Frown Incision Arm: Patients receive MSICS with a frown-shaped scleral incision.

Interventions/Control_3

Chevron Incision Arm: Patients receive MSICS with a chevron (inverted V-shaped) scleral incision.

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

Adults aged 40 to 80 years.

Diagnosed with age-related cataract.

Scheduled for manual small incision cataract surgery (MSICS).

Preoperative visual acuity < 1/10 (Snellen equivalent).

Provided written informed consent.

Surgery performed at CHU-IOTA, Bamako, Mali under a standardized protocol.

Key exclusion criteria

Pre-existing corneal abnormalities.

Irregular astigmatism.

History of ocular surgery in the operated eye.

Any condition that would interfere with accurate keratometric or visual assessment.

Target sample size

150


Research contact person

Name of lead principal investigator

1st name Nouhoum
Middle name
Last name Guirou

Organization

Centre Hospitalier Universitaire / Institut d'ophtalmologie Tropicale d'Afrique (CHU-IOTA)

Division name

Ophthalmology/Oculoplastics

Zip code

91093

Address

Boulevard du Peuple Centre commercial Bamako/Mali

TEL

+22366809004

Email

guiroun@gmail.com


Public contact

Name of contact person

1st name Nouhoum
Middle name
Last name Guirou

Organization

Centre Hospitalier Universitaire / Institut d'ophtalmologie Tropicale d'Afrique (CHU-IOTA)

Division name

Ophthalmology/Oculoplastics

Zip code

91093

Address

Boulevard du Peuple Centre commercial Bamako/Mali

TEL

+22366809004

Homepage URL


Email

guiroun@gmail.com


Sponsor or person

Institute

Centre Hospitalier Universitaire / Institut d'ophtalmologie Tropicale d'Afrique (CHU-IOTA)

Institute

Department

Personal name



Funding Source

Organization

Centre Hospitalier Universitaire / Institut d'ophtalmologie Tropicale d'Afrique (CHU-IOTA)

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Centre Hospitalier Universitaire / Institut d'ophtalmologie Tropicale d'Afrique (CHU-IOTA)

Address

Boulevard du Peuple Centre commercial Bamako/Mali

Tel

+22366809004

Email

guiroun@gmail.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 06 Month 02 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

150

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2024 Year 01 Month 01 Day

Date of IRB

2024 Year 01 Month 01 Day

Anticipated trial start date

2024 Year 01 Month 01 Day

Last follow-up date

2024 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2025 Year 06 Month 02 Day

Last modified on

2025 Year 06 Month 02 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066345